Michael Viksman, MD
Allergy · Toms River, NJNPI 1972668747
Payments from drug & device makers
Across 520 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Genentech USA, Inc.$565
- Novartis$515
- Regeneron Healthcare Solutions, Inc.$499
- Sanofi$367
- plus $2K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 174 | $2,332 |
| AstraZeneca | 101 | $1,801 |
| Genentech USA, Inc. | 34 | $565 |
| Novartis | 33 | $515 |
| Regeneron Healthcare Solutions, Inc. | 23 | $499 |
| Sanofi | 20 | $367 |
| Amgen | 21 | $303 |
| Optinose US, Inc. | 16 | $222 |
| Teva Pharmaceuticals USA, Inc. | 14 | $217 |
| Kaleo, Inc. | 15 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $152 |
| AbbVie | 10 | $145 |
| LEO Pharma Inc. | 6 | $98 |
| Biocryst US Sales Co., LLC | 6 | $96 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $83 |
| Merck | 4 | $60 |
| Boehringer Ingelheim | 4 | $56 |
| Hikma Pharmaceuticals USA | 3 | $47 |
| CSL Behring | 3 | $40 |
| Philips North America LLC | 2 | $38 |
| Grifols USA, LLC | 2 | $36 |
| Phadia US Inc. | 2 | $33 |
| Mylan Specialty L.p. | 2 | $33 |
| Ionis Pharmaceuticals, Inc. | 2 | $33 |
| Blueprint Medicines Corporation | 2 | $33 |
| Octapharma USA, Inc. | 1 | $22 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Incyte Corporation | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
How this compares
$8,122 in reported general payments places this provider in the 55th percentile of 35 allergy providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Toms River
- John OppenheimerCedar Knolls$923K
- Jeffrey WeissRiverdale$836K
- Jay KashkinFair Lawn$486K
- Gregory TociMarlton$317K
- Jun YangTinton Falls$213K
- Shashank ShethVoorhees$127K
- Mathew VargheseNorth Bergen$93K
- Eugene GattiMarlton$43K
- Howard DruceSomerville$37K
- Donatella GraffinoCedar Knolls$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.